5240 articles
announced (March 2021) that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, studying the potential of chimeric ...
Jeff Ruby, Founder and CEO of Newtopia, a habit change provider focused on chronic disease prevention, discusses his perspective on why both telehealth ...
Licensed marriage and family therapist and certified grief and trauma counselor, Kara Bowman discusses her new book entitled "Heartbreak to Hope: Poems ...
Danny Altmann, Chairperson of the Global T cell Expert Consortium (GTEC) and Professor of Immunology at Imperial College London discusses the different ...
Eric Klein, Chairman of the Glickman Urological and Kidney Institute at Cleveland Clinic discusses new 20-year outcomes from a development study of the ...
Melissa Fritsche, discusses what she has observed firsthand within her private practice pertaining to the pandemic exacerbating symptoms of alcohol-rela...
Dave Ross, VP of Commercial Operations - North America at Seqirus discusses the recent FDA approval of FLUCELVAX® QUADRIVALENT, Seqirus’ cell-based q...
Travis Mickle, PhD, President and CEO of KemPharm, Inc., discusses the FDA approval of their new ADHD drug AZSTARYS™ (serdexmethylphenidate and dexmet...
Returning guest, Larry Kemp, owner of Kemp and Sons General Services discusses how he’s had to restructure his business to stay afloat during COVID-19. He...
Michael Breus, a board-certified clinical psychologist and also known as "The Sleep Doctor" discusses insomnia, the causes, and what some experts are ca...